DOP27 Transanal minimally invasive surgery (TAMIS): A novel approach for treatment of pouch failure
ECCO'20 Vienna
2020
DOP28 Understanding the molecular mechanisms of anti-TNF treatment failure in patients with Crohn’s disease: A pilot serum proteomic analysis of the PANTS cohort
ECCO'20 Vienna
2020
DOP30 Multi-‘omics profiling in patients with quiescent inflammatory bowel disease identifies biomarkers predicting relapse
ECCO'20 Vienna
2020
DOP31 Serum protein markers for early and differential IBD diagnosis validated by machine learning approaches
ECCO'20 Vienna
2020
DOP34 Transplantation of human intestine into the mouse: A novel platform for study of inflammatory enterocutaneous fistulas
ECCO'20 Vienna
2020
DOP35 Monitoring of mucosal T cells subsets under biotherapies in IBD: responders exhibit a phenotype similar to healthy controls
ECCO'20 Vienna
2020
DOP36 Family-specific host genetic and gut microbial signatures have a beneficial role in early identification of familial inflammatory bowel diseases
ECCO'20 Vienna
2020
DOP37 Neoplastic lesions outside diseased area in inflammatory bowel disease patients: A national cohort study
ECCO'20 Vienna
2020
DOP38 Prevalence of fatigue in a severe inflammatory bowel disease cohort highly exposed to biologics
ECCO'20 Vienna
2020
DOP41 Low-grade dysplasia prognosis and predictive factors for advanced neoplasia progression in the 21st century: A large multi-centre retrospective cohort study
ECCO'20 Vienna
2020
DOP42 Impact of discontinuing thiopurines at anti-TNF initiation in inflammatory bowel disease: A nationwide Danish cohort study
ECCO'20 Vienna
2020
DOP43 The risk of extra-intestinal cancer in inflammatory bowel disease (IBD): A systematic review and meta-analysis of population-based cohort studies
ECCO'20 Vienna
2020
DOP44 Cancer risk in a high-incidence inflammatory bowel disease population: a Faroese IBD cohort study
ECCO'20 Vienna
2020